Epygen Biotech is a Biopharmaceutical company, engaged in research and manufacturing of Therapeutic Proteins for Oncology, Cardiovascular, Immune disorders and Vaccines. The group’s decades long experience in expression of recombinant protein and innovations in protein separation is utilized in making affordable biologics for patients in the region.